Expanding the Orphanage for Orphan Drugs

Here's a great article outlining the IDSA's efforts to work with the FDA to expand the definition of “orphan” drug to include antibiotics. I think we can all agree that these agents have been treated like unwanted foster stepchildren by pharma. Perhaps this can be the “game changer”?!

http://www.fiercebiotech.com/story/fda-nudged-treat-antibiotics-rare-disease-drugs/2012-03-09

David G. Armstrong

Dedicated to amputation prevention, wound healing, diabetic foot, biotechnology and the intersection between medical devices and consumer electronics.

Leave a Reply